Sinovac Biotech Ltd. Loss Submission Form
Levi & Korsinsky announces the commencement of a class action lawsuit in District of New Jersey on behalf of shareholders of Sinovac Biotech Ltd. (NASDAQ : SVA) who purchased shares between 2013-04-30 and 2017-05-16.
The complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendant Weidong Yin, Sinovac’s Chairman and CEO, bribed a member of the Chinese Food and Drug Administration to assist Sinovac’s vaccine clinical trial and approval; (2) Yin's conduct would subject Sinovac to heightened regulatory scrutiny; and (3) subsequently, Sinovac’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Sinovac Biotech Ltd. you have until 2017-09-01 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
To receive more information, please fill out the form.